These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15797960)

  • 41. Screening for non-classic congenital adrenal hyperplasia in women: New insights using different immunoassays.
    Nakhleh A; Saiegh L; Shehadeh N; Weintrob N; Sheikh-Ahmad M; Supino-Rosin L; Alboim S; Gendelman R; Zloczower M
    Front Endocrinol (Lausanne); 2022; 13():1048663. PubMed ID: 36704043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antenatal corticosteroids and newborn screening for congenital adrenal hyperplasia.
    King JL; Naber JM; Hopkin RJ; Repaske DR; Bailey L; Leslie ND
    Arch Pediatr Adolesc Med; 2001 Sep; 155(9):1038-42. PubMed ID: 11529806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
    Lee JE; Moon Y; Lee MH; Jun YH; Oh KI; Choi JW
    Ann Clin Lab Sci; 2008; 38(3):235-40. PubMed ID: 18715851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Home monitoring of 17 hydroxyprogesterone levels in congenitx127drenal hyperplasia with filter paper blood samples.
    Bode HH; Rivkees SA; Cowley DM; Pardy K; Johnson S
    J Pediatr; 1999 Feb; 134(2):185-9. PubMed ID: 9931527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.
    Tsuji A; Konishi K; Hasegawa S; Anazawa A; Onishi T; Ono M; Morio T; Kitagawa T; Kashimada K
    BMC Pediatr; 2015 Dec; 15():209. PubMed ID: 26671474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liquid chromatography-tandem mass spectrometric method for determination of salivary 17alpha-hydroxyprogesterone: a noninvasive tool for evaluating efficacy of hormone replacement therapy in congenital adrenal hyperplasia.
    Shibayama Y; Higashi T; Shimada K; Kashimada K; Onishi T; Ono M; Miyai K; Mizutani S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):49-56. PubMed ID: 18378505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ten-year evaluation of a Neonatal Screening Program for congenital adrenal hyperplasia.
    Nascimento ML; Cristiano AN; Campos Td; Ohira M; Cechinel E; Simoni G; Lee Jv; Linhares RM; Silva PC
    Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):765-71. PubMed ID: 25372587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A three-year follow-up of congenital adrenal hyperplasia newborn screening.
    Pezzuti IL; Barra CB; Mantovani RM; Januário JN; Silva IN
    J Pediatr (Rio J); 2014; 90(3):300-7. PubMed ID: 24560529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cortisol assay in dried blood spots to reduce false positive rate in congenital adrenal hyperplasia screening.
    Brossaud J; Barat P; Fagour L; Corcuff JB
    Clin Chim Acta; 2012 Aug; 413(15-16):1306-7. PubMed ID: 22561187
    [No Abstract]   [Full Text] [Related]  

  • 50. High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland.
    Steigert M; Schoenle EJ; Biason-Lauber A; Torresani T
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4106-10. PubMed ID: 12213856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
    Fingerhut R
    Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. First ISNS Reference Preparation for Neonatal Screening for thyrotropin, phenylalanine and 17alpha-hydroxyprogesterone in blood spots.
    Elvers LH; Loeber JG; Dhondt JL; Fukushi M; Hannon WH; Torresani T; Webster D
    J Inherit Metab Dis; 2007 Aug; 30(4):609. PubMed ID: 17574536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simultaneous quantification of 17α-OH progesterone, 11-deoxycortisol, Δ4-androstenedione, cortisol and cortisone in newborn blood spots using liquid chromatography-tandem mass spectrometry.
    Magnisali P; Chalioti MB; Livadara T; Mataragas M; Paliatsiou S; Malamitsi-Puchner A; Moutsatsou P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1565-72. PubMed ID: 21514253
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
    Gu X; Zhou J; Ye J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):16-8. PubMed ID: 11955341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adrenal steroid profiling as a diagnostic tool to differentiate polycystic ovary syndrome from nonclassic congenital adrenal hyperplasia: pinpointing easy screening possibilities and normal cutoff levels using liquid chromatography tandem mass spectrometry.
    Ueland GÅ; Dahl SR; Methlie P; Hessen S; Husebye ES; Thorsby PM
    Fertil Steril; 2022 Aug; 118(2):384-391. PubMed ID: 35725670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of factors associated with elevated newborn 17-hydroxyprogesterone levels.
    Anandi VS; Shaila B
    J Pediatr Endocrinol Metab; 2017 May; 30(6):677-681. PubMed ID: 28489558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 21-Deoxycortisol is a Key Screening Marker for 21-Hydroxylase Deficiency.
    Held PK; Bialk ER; Lasarev MR; Allen DB
    J Pediatr; 2022 Mar; 242():213-219.e1. PubMed ID: 34780778
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Do we need congenital adrenal hyperplasia screening for premature infants?].
    Huet F; Godefroy A; Cheillan D; Somma C; Roussey M
    Arch Pediatr; 2014 Feb; 21(2):233-6. PubMed ID: 24361036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.
    de Hora MR; Heather NL; Webster D; Albert BB; Hofman PL
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3390-e3399. PubMed ID: 34058748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationships of basal level of serum 17-hydroxyprogesterone with that of serum androstenedione and their stimulated responses to a low dose of ACTH in young adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Kang MJ; Kim SM; Lee YA; Shin CH; Yang SW
    J Korean Med Sci; 2011 Nov; 26(11):1454-60. PubMed ID: 22065901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.